Form 8-K - Current report:
SEC Accession No. 0001140361-23-000929
Filing Date
2023-01-09
Accepted
2023-01-09 09:10:22
Documents
12
Period of Report
2023-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10046438_8k.htm   iXBRL 8-K 34079
  Complete submission text file 0001140361-23-000929.txt   170178

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20230108.xsd EX-101.SCH 3875
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20230108_lab.xml EX-101.LAB 22547
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20230108_pre.xml EX-101.PRE 16051
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10046438_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 23516854
SIC: 2834 Pharmaceutical Preparations